These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17264150)

  • 1. IL-13 mediates the recruitment of reserve cells for fusion during IGF-1-induced hypertrophy of human myotubes.
    Jacquemin V; Butler-Browne GS; Furling D; Mouly V
    J Cell Sci; 2007 Feb; 120(Pt 4):670-81. PubMed ID: 17264150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-1 induces human myotube hypertrophy by increasing cell recruitment.
    Jacquemin V; Furling D; Bigot A; Butler-Browne GS; Mouly V
    Exp Cell Res; 2004 Sep; 299(1):148-58. PubMed ID: 15302582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-I inhibits dexamethasone-induced proteolysis in cultured L6 myotubes through PI3K/Akt/GSK-3beta and PI3K/Akt/mTOR-dependent mechanisms.
    Li BG; Hasselgren PO; Fang CH
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2207-16. PubMed ID: 15927518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle-specific overexpression of the type 1 IGF receptor results in myoblast-independent muscle hypertrophy via PI3K, and not calcineurin, signaling.
    Quinn LS; Anderson BG; Plymate SR
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1538-51. PubMed ID: 17940216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dynamic ribosomal biogenesis response is not required for IGF-1-mediated hypertrophy of human primary myotubes.
    Crossland H; Timmons JA; Atherton PJ
    FASEB J; 2017 Dec; 31(12):5196-5207. PubMed ID: 28774889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin and wnt1 pathways cooperate to induce reserve cell activation in differentiation and myotube hypertrophy.
    Rochat A; Fernandez A; Vandromme M; Molès JP; Bouschet T; Carnac G; Lamb NJ
    Mol Biol Cell; 2004 Oct; 15(10):4544-55. PubMed ID: 15282335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.
    Rommel C; Bodine SC; Clarke BA; Rossman R; Nunez L; Stitt TN; Yancopoulos GD; Glass DJ
    Nat Cell Biol; 2001 Nov; 3(11):1009-13. PubMed ID: 11715022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of REDD1 by insulin-like growth factor-I in skeletal muscle and myotubes.
    Frost RA; Huber D; Pruznak A; Lang CH
    J Cell Biochem; 2009 Dec; 108(5):1192-202. PubMed ID: 19795384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.
    Glass DJ
    Curr Top Microbiol Immunol; 2010; 346():267-78. PubMed ID: 20593312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
    Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
    J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor (IGF-I) induces myotube hypertrophy associated with an increase in anaerobic glycolysis in a clonal skeletal-muscle cell model.
    Semsarian C; Sutrave P; Richmond DR; Graham RM
    Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):443-51. PubMed ID: 10191278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone enables growth and hypertrophy in fusion impaired myoblasts that display myotube atrophy: deciphering the role of androgen and IGF-I receptors.
    Hughes DC; Stewart CE; Sculthorpe N; Dugdale HF; Yousefian F; Lewis MP; Sharples AP
    Biogerontology; 2016 Jun; 17(3):619-39. PubMed ID: 26538344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AICAR-induced activation of AMPK negatively regulates myotube hypertrophy through the HSP72-mediated pathway in C2C12 skeletal muscle cells.
    Egawa T; Ohno Y; Goto A; Ikuta A; Suzuki M; Ohira T; Yokoyama S; Sugiura T; Ohira Y; Yoshioka T; Goto K
    Am J Physiol Endocrinol Metab; 2014 Feb; 306(3):E344-54. PubMed ID: 24347059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt.
    Morissette MR; Cook SA; Buranasombati C; Rosenberg MA; Rosenzweig A
    Am J Physiol Cell Physiol; 2009 Nov; 297(5):C1124-32. PubMed ID: 19759331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF-I does not prevent myotube atrophy caused by proinflammatory cytokines despite activation of Akt/Foxo and GSK-3beta pathways and inhibition of atrogin-1 mRNA.
    Dehoux M; Gobier C; Lause P; Bertrand L; Ketelslegers JM; Thissen JP
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E145-50. PubMed ID: 16926385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor I-mediated skeletal muscle hypertrophy is characterized by increased mTOR-p70S6K signaling without increased Akt phosphorylation.
    Song YH; Godard M; Li Y; Richmond SR; Rosenthal N; Delafontaine P
    J Investig Med; 2005 Apr; 53(3):135-42. PubMed ID: 15921033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of interleukin-15 induces skeletal muscle hypertrophy in vitro: implications for treatment of muscle wasting disorders.
    Quinn LS; Anderson BG; Drivdahl RH; Alvarez B; Argilés JM
    Exp Cell Res; 2002 Oct; 280(1):55-63. PubMed ID: 12372339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF-II is up-regulated and myofibres are hypertrophied in regenerating soleus of mice lacking FGF6.
    Armand AS; Lécolle S; Launay T; Pariset C; Fiore F; Della Gaspera B; Birnbaum D; Chanoine C; Charbonnier F
    Exp Cell Res; 2004 Jul; 297(1):27-38. PubMed ID: 15194422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of MAP/ERK kinase prevents IGF-I-induced hypertrophy in rat muscles.
    Haddad F; Adams GR
    J Appl Physiol (1985); 2004 Jan; 96(1):203-10. PubMed ID: 12959952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone promotes skeletal muscle cell fusion independent of insulin-like growth factor 1 up-regulation.
    Sotiropoulos A; Ohanna M; Kedzia C; Menon RK; Kopchick JJ; Kelly PA; Pende M
    Proc Natl Acad Sci U S A; 2006 May; 103(19):7315-20. PubMed ID: 16670201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.